GLP-1 products, or Glucagon-like peptide-1 receptor agonists, are a type of medication that can help manage blood sugar levels and often lead to weight loss. They work by increasing the production of insulin, a hormone that lowers blood sugar, and by decreasing the amount of glucose that the liver produces.

Semaglutide is a medication classified as a glucagon-like peptide-1 (GLP-1) receptor agonist. It mimics the GLP-1 hormone that is released in the gastrointestinal tract in response to eating.

Tirzepatide is a dual-acting GLP-1 and glucose-dependent insulinotropic polypeptide (also called GIP) receptor agonist with substantial efficacy for weight reduction in individuals with overweight and obesity.

After checking out and completing our intake form, one of DocIndy's providers will reach out to you over the phone or through text message to answer any other questions they have. Most encounters are completed over text message, and only require confirmation of details on your part.

Most patients receive their medication within a week of placing their order. Our doctors require some personal information from you before DocIndy is able to send out your medication, which is mostly covered by our intake form.

Side effects of GLP-1 products can include nausea, vomiting, diarrhea, and constipation. However, these side effects are usually mild and improve over time.

Yes and no. For oral semaglutide, you do require diabetes. But for other types of GLP-1, you don't need diabetes but you would need to be approved for using it for chronic weight management. Some simple factors our doctors would look at are your BMI and waist circumference.